Background The efficacy of screening by mammography has been shown in randomised
controlled trials in women aged 50 years and older, but is less clear in younger women. A …

Background Age-specific effects of mammographic screening, and the timing of such effects,
are a matter of debate. The results of the UK Age trial, which compared the effect of invitation …

Background The appropriate age range for breast cancer screening remains a matter of
debate. We aimed to estimate the effect of mammographic screening at ages 40–48 years …

Objective Although there is clear evidence from randomised trials of the effectiveness of
mammographic screening in women over 50 in reducing mortality from breast cancer, the …

Eight randomized controlled trials (RCTs) of screening mammography have been conducted
involving women aged 40-49 at entry. Current data are now available from these trials at …

The early trials of screening mammography, reporting 30% relative reduction in mortality
from breast cancer in women over 50 years of age, led to strong professional and public …

Background There has been much debate about the value of screening mammography.
Here we update the overview of the Swedish randomised controlled trials on mammography …

Objective: A previous review by the Canadian Task Force on the Periodic Health
Examination (now the Canadian Task Force on Preventive Health Care) in 1994 indicated …

Early detection of breast cancer through screening can lower breast cancer mortality rates
and reduce the burden of this disease in the population. In most western countries …

BACKGROUND There remains disagreement on the long-term effect of mammographic
screening in women aged 40-49 years. OBJECTIVES The long-term follow-up of a …